TB, HIV, and the world

Every year, TB and HIV jeopardize the lives of millions of people who lack access to existing treatments due to poverty, conflict, and marginalization.

In 2024, 1.3 million people lost their lives to TB, making it the most common cause of death due to an infectious disease in the world.

Another 9.2 million people with HIV could not access treatment in 2024, endangering their survival and further spreading HIV infection.

TB has been and continues to be the largest cause of death in persons with HIV/AIDS, even though TB is curable, even in people with advanced AIDS.

TB has caused the death of a third to a half of the 42 million people who have died of AIDS since AIDS emerged in the early 1980s.

Drug resistant (DR) TB occurs when the TB bacteria mutates and becomes resistant to antibiotics used to treat ‘regular’ TB. Treatment requires drugs with many side-effects and because of the delays in diagnosis and treatment many patients cycle through ineffective treatments and our left with damaged lungs and hearts even if cured.

When drug resistant TB infects and causes disease in persons with HIV/AIDS, mortality increases 12-fold and is particularly deadly.

How does GHC provide access to treatment, save lives, & create sustainable change?

We work with local staff, communities and national programs to ensure people have access to treatment for TB, drug resistant TB, and HIV care.

We integrate our programs into the local and national health care systems in the countries where we work, so the health infrastructure is strengthened.

We provide each patient with the best care possible while improving standards of local and global care.

We save lives with the medicines we have in our hands and decrease suffering now.

In tandem, we use science to find new and better treatments for the future.